Amgen Total Assets from 2010 to 2024

AMGN Stock  USD 286.30  4.53  1.61%   
Amgen Total Assets yearly trend continues to be very stable with very little volatility. Total Assets are likely to grow to about 102 B this year. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals
 
Total Assets  
First Reported
1986-03-31
Previous Quarter
90.5 B
Current Value
97.2 B
Quarterly Volatility
28.9 B
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Amgen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amgen main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.3 B, Interest Expense of 3 B or Selling General Administrative of 5.8 B, as well as many exotic indicators such as Short Term Coverage Ratios of 5.58, Price Earnings Ratio of 21.79 or Price To Sales Ratio of 9.08. Amgen financial statements analysis is a perfect complement when working with Amgen Valuation or Volatility modules.
  
This module can also supplement Amgen's financial leverage analysis and stock options assessment as well as various Amgen Technical models . Check out the analysis of Amgen Correlation against competitors.

Latest Amgen's Total Assets Growth Pattern

Below is the plot of the Total Assets of Amgen Inc over the last few years. Total assets refers to the total amount of Amgen assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Amgen Inc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Amgen's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amgen's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 97.15 B10 Years Trend
Slightly volatile
   Total Assets   
       Timeline  

Amgen Total Assets Regression Statistics

Arithmetic Mean65,471,693,333
Geometric Mean44,300,133,411
Coefficient Of Variation35.31
Mean Deviation14,146,420,444
Median66,125,000,000
Standard Deviation23,115,372,757
Sample Variance534320457.7T
Range101.9B
R-Value0.68
Mean Square Error309272719.3T
R-Squared0.46
Significance0.01
Slope3,515,242,857
Total Sum of Squares7480486407.6T

Amgen Total Assets History

2024102 B
202397.2 B
202265.1 B
202161.2 B
202062.9 B
201959.7 B
201866.4 B

About Amgen Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Amgen income statement, its balance sheet, and the statement of cash flows. Amgen investors use historical funamental indicators, such as Amgen's Total Assets, to determine how well the company is positioned to perform in the future. Although Amgen investors may use each financial statement separately, they are all related. The changes in Amgen's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Amgen's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Amgen Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Amgen. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Total Assets97.2 B102 B

Pair Trading with Amgen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amgen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amgen will appreciate offsetting losses from the drop in the long position's value.

Moving together with Amgen Stock

  0.62MBIO Mustang Bio Report 3rd of April 2024 PairCorr

Moving against Amgen Stock

  0.76EQ Equillium Financial Report 9th of May 2024 PairCorr
  0.73TCRX Tscan Therapeutics Financial Report 8th of May 2024 PairCorr
  0.65DNLI Denali Therapeutics Financial Report 13th of May 2024 PairCorr
  0.6VANI Vivani Medical Report 29th of March 2024 PairCorr
  0.56MDGL Madrigal Pharmaceuticals Financial Report 14th of May 2024 PairCorr
The ability to find closely correlated positions to Amgen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amgen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amgen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amgen Inc to buy it.
The correlation of Amgen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amgen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amgen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amgen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:
Check out the analysis of Amgen Correlation against competitors.
Note that the Amgen Inc information on this page should be used as a complementary analysis to other Amgen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Complementary Tools for Amgen Stock analysis

When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Equity Valuation
Check real value of public entities based on technical and fundamental data
Is Amgen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amgen. If investors know Amgen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amgen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.52)
Dividend Share
8.52
Earnings Share
12.48
Revenue Per Share
52.692
Quarterly Revenue Growth
0.198
The market value of Amgen Inc is measured differently than its book value, which is the value of Amgen that is recorded on the company's balance sheet. Investors also form their own opinion of Amgen's value that differs from its market value or its book value, called intrinsic value, which is Amgen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amgen's market value can be influenced by many factors that don't directly affect Amgen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amgen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amgen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amgen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.